• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Professional Introduction to α-Ethyl-N-formyl-N-methylpyridinemethaneamine (CAS No. 887355-12-6)

α-Ethyl-N-formyl-N-methylpyridinemethaneamine, a compound with the chemical identifier CAS No. 887355-12-6, represents a significant area of interest in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, characterized by its unique structural framework, has garnered attention for its potential applications in the development of novel therapeutic agents and synthetic intermediates. The intricate arrangement of functional groups within its molecular structure, including the N-formyl and N-methyl substituents, makes it a versatile building block for further chemical modifications and derivatization.

The synthesis and characterization of α-Ethyl-N-formyl-N-methylpyridinemethaneamine have been subjects of extensive research in academic and industrial laboratories. Recent advancements in synthetic methodologies have enabled more efficient and scalable production processes, which are crucial for its integration into larger drug discovery programs. The compound's reactivity profile, particularly its ability to participate in nucleophilic addition reactions, has been leveraged to develop novel heterocyclic compounds with enhanced pharmacological properties.

In the realm of medicinal chemistry, α-Ethyl-N-formyl-N-methylpyridinemethaneamine has been explored as a precursor for the synthesis of bioactive molecules targeting various disease pathways. For instance, studies have demonstrated its utility in generating derivatives that exhibit inhibitory effects on enzymes implicated in inflammatory responses and metabolic disorders. These findings align with the broader trend toward developing small molecule inhibitors that modulate critical biological processes through precise molecular interactions.

The compound's structural motif, featuring a pyridine core with ethyl and formyl functional groups, has also been investigated for its potential role in drug-receptor binding interactions. Computational studies have suggested that modifications to this scaffold could enhance binding affinity and selectivity for specific therapeutic targets. Such insights are invaluable for designing next-generation drugs with improved efficacy and reduced side effects.

Moreover, the N-formyl group in α-Ethyl-N-formyl-N-methylpyridinemethaneamine serves as a versatile handle for further functionalization, allowing chemists to introduce additional substituents or linkages as needed. This flexibility has been exploited in the development of conjugates and prodrugs designed to enhance bioavailability or targeted delivery to specific tissues. The compound's potential as a chiral intermediate has also been explored, with researchers investigating methods to produce enantiomerically pure forms for use in asymmetric synthesis.

Recent research has highlighted the importance of understanding the mechanistic aspects of reactions involving α-Ethyl-N-formyl-N-methylpyridinemethaneamine. By elucidating reaction pathways at a molecular level, scientists can optimize synthetic routes and predict the outcomes of novel modifications. This knowledge is essential for ensuring reproducibility and scalability in industrial settings, where consistency is paramount.

The application of high-throughput screening technologies has further accelerated the discovery process by enabling rapid assessment of large libraries of derivatives derived from α-Ethyl-N-formyl-N-methylpyridinemethaneamine. These approaches have identified several promising candidates with unique pharmacological profiles, paving the way for preclinical development studies. Collaborative efforts between academic institutions and pharmaceutical companies have been instrumental in translating these findings into tangible therapeutic benefits.

The safety and environmental impact of working with α-Ethyl-N-formyl-N-methylpyridinemethaneamine have also been carefully evaluated. Modern synthetic protocols emphasize green chemistry principles, minimizing waste generation and utilizing sustainable solvents where possible. Such practices ensure that research activities remain aligned with global standards for environmental responsibility while maintaining high standards of laboratory safety.

As our understanding of biological systems continues to evolve, so too does the role of compounds like α-Ethyl-N-formyl-N-methylpyridinemethaneamine in drug discovery. Emerging technologies such as CRISPR gene editing and artificial intelligence-driven molecular design are opening new avenues for exploring its potential applications. By integrating these innovations with traditional chemical methodologies, researchers can accelerate the development of novel therapeutics that address unmet medical needs.

In conclusion, α-Ethyl-N-formyl-N-methylpyridinemethaneamine represents a compelling example of how structural diversity can be leveraged to develop innovative pharmaceuticals. Its unique combination of reactivity features makes it a valuable tool for synthetic chemists and medicinal chemists alike. As research progresses, this compound is likely to play an increasingly important role in shaping the future of drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)